Disrupting HIV/AIDS transmission

In the early 1980s a newly emerging, unknown disease was causing panic. There was no viable treatment, vaccine or cure. Nobody could fight it.

Then in 1987, a young Argentine-Canadian physician who had specialized in respiratory diseases, was put in charge of St. Paul’s Hospital/UBC’s AIDS Research Program and the Infectious Disease Clinic. At the time, there were many – mostly young – men being admitted to the hospital who were suffering from a lethal form of pneumonia known as PCP (pneumocystis pneumonia) and the young physician started asking questions.

Those questions changed the course of history.

That inquisitive physician: Dr. Julio Montaner, UBC faculty member and pioneering HIV researcher, who went on to lead the innovation of a highly active antiretroviral therapy (HAART). This combination therapy effectively stopped HIV’s disease progression to AIDS.

Montaner has since led the world out of the dark days of AIDS with this life-saving antiretroviral therapy, as well as a forward-thinking treatment strategy.

If implemented worldwide, the made-in-BC medical application – Treatment as Prevention¨ (TasP¨) – has the potential to stop a global epidemic in its tracks.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below